Cargando…
Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin
A hallmark of clear cell renal cell carcinoma (ccRCC) is the presence of intracellular lipid droplets (LD) and it is assumed that phosphatidic acid (PA) produced by phospholipase D (PLD) plays some role in the LD formation. However, little is known about the significance of PLD in ccRCC. In this stu...
Autores principales: | Kandori, Shuya, Kojima, Takahiro, Matsuoka, Taeko, Yoshino, Takayuki, Sugiyama, Aiko, Nakamura, Eijiro, Shimazui, Toru, Funakoshi, Yuji, Kanaho, Yasunori, Nishiyama, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989877/ https://www.ncbi.nlm.nih.gov/pubmed/29660846 http://dx.doi.org/10.1111/cas.13609 |
Ejemplares similares
-
Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study
por: Kandori, Shuya, et al.
Publicado: (2016) -
Physiological function of phospholipase D2 in anti-tumor immunity: regulation of CD8(+) T lymphocyte proliferation
por: Ngo Thai Bich, Van, et al.
Publicado: (2018) -
ELOVL5‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma
por: Nitta, Satoshi, et al.
Publicado: (2022) -
Ubiquitin-specific protease TRE17/USP6 promotes tumor cell invasion through the regulation of glycoprotein CD147 intracellular trafficking
por: Ogura, Yukino, et al.
Publicado: (2022) -
ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma
por: Tanaka, Ken, et al.
Publicado: (2022)